Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52

1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; 2Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; 3Molecular Insight Pharmaceuticals, Cambridge, Massachusetts; 4Bayer Pharma AG, Research Laboratories, Berlin, Germany; and 5Department of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany